Supporting translational research infrastructure to develop new therapeutics for human health
Leadership
TIA has brought together 14 national research infrastructure facilities to accelerate translation of Australian research discoveries to clinical application. These facilities focus on delivering critical services to support development of different classes of therapeutic products ie. Biologics, Cell and Gene Therapies and Small Molecules, with each facility led by world-class researchers as listed below.
Dr Ben Carnley
Acting Director
Cell and Tissue Therapies
Western Australia
Dr Leanne Hawkey
Facility Manager
Australian Translational Medicinal Chemistry Facility
Wilma James
Strategic Business Manager Compounds Australia
Darron Laing
Facility Manager
Q-Gen Cell Therapeutics
Dr Leon Scott
General Manager
Q-Gen Cell Therapeutics
CSO Cell Therapies Pty Ltd
PeterMac Centre of Excellence in Cellular Immunotherapy
Dr Melina Wilsson
Facility Manager
ANZCTR